Nanjing Pharmaceutical Group Company Limited (SHA:600713)
4.980
+0.010 (0.20%)
Jun 18, 2026, 3:00 PM CST
-4.60% (1Y)
| Market Cap | 6.51B -4.3% |
| Revenue (ttm) | 54.56B +1.1% |
| Net Income | 622.04M +5.6% |
| EPS | 0.41 -8.0% |
| Shares Out | 1.31B |
| PE Ratio | 12.00 |
| Forward PE | n/a |
| Dividend | 0.17 (3.38%) |
| Ex-Dividend Date | Jun 30, 2025 |
| Volume | 7,188,400 |
| Open | 4.970 |
| Previous Close | 4.970 |
| Day's Range | 4.930 - 5.020 |
| 52-Week Range | 4.810 - 6.650 |
| Beta | 0.24 |
| Analysts | Strong Buy |
| Price Target | 11.60 (+132.93%) |
| Earnings Date | Aug 28, 2026 |